Currently, there are 1.76B common shares owned by the public and among those 1.69B shares have been available to trade.
The company’s stock has a 5-day price change of 0.73% and 7.06% over the past three months. MO shares are trading 40.68% year to date (YTD), with the 12-month market performance up to 36.85% higher. It has a 12-month low price of $39.25 and touched a high of $56.84 over the same period. MO has an average intraday trading volume of 7.79 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.00%, 9.20%, and 19.40% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Altria Group Inc (NYSE: MO) shares accounts for 60.66% of the company’s 1.76B shares outstanding.
It has a market capitalization of $97.38B and a beta (3y monthly) value of 0.66. The stock’s trailing 12-month PE ratio is 9.58, while the earnings-per-share (ttm) stands at $5.92. The company has a PEG of 2.30 and a Quick Ratio of 0.30. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.25% over the week and 1.70% over the month.
Earnings per share for the fiscal year are expected to increase by 3.43%, and 4.21% over the next financial year. EPS should shrink at an annualized rate of 4.16% over the next five years, compared to 4.39% over the past 5-year period.
Looking at the support for the MO, a number of firms have released research notes about the stock. Citigroup stated their Neutral rating for the stock in a research note on October 08, 2024, with the firm’s price target at $44.50-$48. Stifel was of a view on April 14, 2023 that the stock is Buy, while UBS gave the stock Sell rating on November 10, 2022, issuing a price target of $38. Barclays on their part issued Underweight rating on June 29, 2022.
